Few would argue that 2020 was a year in which our collective and individual visions of the present and future were not profoundly impacted. In light of this, several studies were conducted over the ...
As noted in the first installment of this series investigating spending trends on automation technology across the discrete, batch, and continuous process industry verticals, this second installment ...
Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results